ABL1 and leukemia: Here, we used the BCR-ABL+ cell line BV173 and a PDX model in NSG mice that both developed aggressive leukemia associated with reduced heart weight and size, impaired LV function, reduced cardiomyocyte CSA and enhanced cardiac apoptosis.